Patient-reported outcomes and health-related quality of life after urinary diversions.
Journal
Current opinion in urology
ISSN: 1473-6586
Titre abrégé: Curr Opin Urol
Pays: United States
ID NLM: 9200621
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
pubmed:
22
6
2021
medline:
29
6
2022
entrez:
21
6
2021
Statut:
ppublish
Résumé
To study the recent literature on health-related quality of life (HRQOL) in patients after radical cystectomy followed by urinary diversion. General consensus regarding, which urinary diversion is superior in terms of HRQOL has not been reached. Although there is an increase in studies favoring the orthotopic neobladder, overall quality of these studies is poor. Other studies suggest that HRQOL outcomes in different types of urinary diversions is similar and that other factors, such as age, comorbidities and sex are more important instead. Patient choice, in consultation with the treating surgeon should be the determinant of which urinary diversion is performed. Furthermore, sexual function can play an important role in HRQOL. However, practice shows that counselling on the option of sexual-preserving techniques is still not implemented in routine clinical practice. Furthermore, studies regarding differences in HRQOL after urinary diversion between male and female individuals are lacking. Thorough preoperative counselling on the different types of urinary diversion and options for sexual-preserving techniques decreases decision regret and increases HRQOL in patients after radical cystectomy.
Identifiants
pubmed: 34148968
doi: 10.1097/MOU.0000000000000906
pii: 00042307-202111000-00010
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
574-579Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63:234–241.
Almassi N, Bochner BH. Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use. Curr Opin Urol 2020; 30:415–420.
Pazeto CL, Baccaglini W, Tourinho-Barbosa RR, et al. HRQOL related to urinary diversion in Radical Cystectomy: a systematic review of recent literature. International braz j urol 2019; 45:1094–1104.
Rammant E, Van Wilder L, Van Hemelrijck M, et al. Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review. Qual Life Res 2020; 29:2887–2910.
Stein JP, Skinner DG. Results with radical cystectomy for treating bladder cancer: a ’reference standard’ for high-grade, invasive bladder cancer. BJU Int 2003; 92:12–17.
Hautmann RE, Volkmer BG, Schumacher MC, et al. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 2006; 24:305–314.
Nieuwenhuijzen JA, de Vries RR, Bex A, et al. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 2008; 53:834–844.
Mues AC, Palacios JM, Haramis G, et al. Contemporary experience in the management of angiomyolipoma. J Endourol 2010; 24:1883–1886.
Cerruto MA, D’Elia C, Siracusano S, et al. Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with ileal orthotopic neobladder or ileal conduit: results from a multicentre cross-sectional study using validated questionnaires. Urol Int 2018; 100:346–352.
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or nonrandomised studies of healthcare interventions, or both. BMJ 2017; 358:j4008.
Singh V, Yadav R, Sinha RJ, Gupta DK. Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model. BJU Int 2014; 113:726–732.
Kern SQ, Speir RW, Tong Y, et al. Longitudinal health related quality of life after open radical cystectomy: comparison of ileal conduit, indiana pouch, and orthotopic neobladder. Urology 2021; 152:184–189.
Catto JWF, Downing A, Mason S, et al. Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes. Eur Urol 2021; 79:621–632.
Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer 2006; 106:2355–2362.
Miyake H, Furukawa J, Muramaki M, et al. Health related quality of life after radical cystectomy: comparative study between orthotopic sigmoid versus ileal neobladders. Eur J Surg Oncol 2012; 38:1089–1094.
Autorino R, Quarto G, Di Lorenzo G, et al. Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. Eur J Surg Oncol 2009; 35:858–864.
McAlpine K, Lavallée LT, Stacey D, et al. Development and acceptability testing of a patient decision aid for urinary diversion with radical cystectomy. J Urol 2019; 202:1001–1007.
Leo MC, Gilbert SM, Wendel CS, et al. Development of a goal elicitation measure to support choice about urinary diversion by patients with bladder cancer. J Urol 2019; 202:83–89.
Rangarajan K, Somani BK. Trends in quality of life reporting for radical cystectomy and urinary diversion over the last four decades: a systematic review of the literature. Arab J Urol 2019; 17:181–194.
McMullen CK, Kwan ML, Colwell JC, et al. Recovering from cystectomy: patient perspectives. Bladder Cancer 2019; 5:51–61.
Check DK, Leo MC, Banegas MP, et al. Decision regret related to urinary diversion choice among patients treated with cystectomy. J Urol 2020; 203:159–163.
Becerra Pérez MM, Menear M, Brehaut JC, Légaré F. Extent and predictors of decision regret about healthcare decisions: a systematic review. Med Decision Making 2016; 36:777–790.
Matsuda T, Aptel I, Exbrayat C, Grosclaude P. Determinants of quality of life of bladder cancer survivors five years after treatment in France. Int J Urol 2003; 10:423–429.
Zippe CD, Raina R, Shah AD, et al. Female sexual dysfunction after radical cystectomy: a new outcome measure. Urology 2004; 63:1153–1157.
Normann CO, Opheim R, Andreassen BK, et al. Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population. Scand J Urol 2020; 54:181–187.
Tostivint V, Verhoest G, Cabarrou B, et al. Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study. World J Urol 2020; [Epub ahead of print].
Kretschmer A, Grimm T, Buchner, et al. Prognostic features for quality of life after radical cystectomy and orthotopic neobladder. Int Braz J Urol 2016; 42:1109–1120.
Zippe CD, Raina R, Massanyi EZ, et al. Sexual function after male radical cystectomy in a sexually active population. Urology 2004; 64:682–685.
Hekal IA, El-Bahnasawy MS, Mosbah A, et al. Recoverability of erectile function in post–radical cystectomy patients: subjective and objective evaluations. Eur Urol 2009; 55:275–283.
Zahran MH, Fahmy O, El-Hefnawy AS, Ali-El-Dein B. Female sexual dysfunction post radical cystectomy and urinary diversion. Climacteric 2016; 19:546–550.
Tuderti G, Mastroianni R, Flammia S, et al. Sex-sparing robot-assisted radical cystectomy with intracorporeal padua ileal neobladder in female: surgical technique, perioperative, oncologic and functional outcomes. J Clin Med 2020; 9:577.
Westerman ME, Kokorovic A, Wang XS, et al. Radical cystectomy and perioperative sexual function: a cross-sectional analysis. J Sex Med 2020; 17:1995–2004.
Gupta N, Kucirka LM, Semerjian A, et al. Comparing provider-led sexual health counseling of male and female patients undergoing radical cystectomy. J Sex Med 2020; 17:949–956.
Voigt M, Hemal K, Matthews C. Influence of simple and radical cystectomy on sexual function and pelvic organ prolapse in female patients: a scoping review of the literature. Sex Med Rev 2019; 7:408–415.
Witjes JA, Compérat E, Cowan NC, et al. European Association of Urology. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014; 65:778–792.
Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 2017; 198:552–559.
Messer JC, Shariat SF, Dinney CP, et al. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology 2014; 83:863–867.
Kluth LA, Rieken M, Xylinas E, et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multiinstitutional study of more than 8000 patients. Eur Urol 2014; 66:913–919.
Novara G, De Marco V, Aragona M, et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009; 182:914–921.
Moeen AM, Safwat AS, Gadelmoula MM, et al. Health related quality of life after urinary diversion. Which technique is better? J Egypt Natl Canc Inst 2018; 30:93–97.
Grimm T, Grimm J, Buchner A, et al. Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes. World J Urol 2019; 37:2385–2392.
Siracusano S, D’Elia C, Cerruto MA, et al. Quality of life in patients with bladder cancer undergoing ileal conduit: a comparison of women versus men. In Vivo 2018; 32:139–143.
Siracusano S, D’Elia C, Cerruto MA, et al. Quality of life following urinary diversion: orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors. Eur J Surg Oncol 2019; 45:477–481.
Smith AB, Crowell K, Woods ME, et al. Functional outcomes following radical cystectomy in women with bladder cancer: a systematic review. Eur Urol Focus 2017; 3:136–143.